Summary of evidence on management of dyspnea in patients with interstitial lung disease
10.3760/cma.j.cn115682-20240517-02793
- VernacularTitle:间质性肺疾病患者呼吸困难管理的证据总结
- Author:
Huifang WANG
1
;
Hongxia SUN
1
;
Di LIU
1
;
Wenjun NIAN
1
;
Lulu XIU
1
Author Information
1. 青岛大学附属医院市南院区呼吸与危重症医学科，青岛 266000
- Publication Type:Journal Article
- Keywords:
Lung diseases, interstitial;
Dyspnea;
Evidence summary;
Evidence-based nursing
- From:
Chinese Journal of Modern Nursing
2025;31(13):1737-1744
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize the evidence on managing dyspnea in patients with interstitial lung disease (ILD) .Methods:Literature on the management of dyspnea in patients with ILD was electronically searched in UpToDate, British Medical Journal (BMJ) Best Practice, American Thoracic Society, National Institute for Health and Clinical Excellence, Joanna Briggs Institute Evidence-Based Health Care Center Database, Cochrane Library, PubMed, Embase, Web of Science, China National Knowledge Infrastructure, China Biology Medicine disc, WanFang Data and other databases and websites. The search period was from database establishment to April 30, 2024. The quality of the included literature was evaluated using the corresponding quality assessment criteria of the literature, and the information was extracted.Results:A total of 18 articles were included, including three clinical decisions, nine guidelines, three expert consensus, two systematic reviews, and one evidence summary. Twenty-four pieces of evidence were ultimately summarized in five areas: dyspnea assessment, oxygen therapy, pulmonary rehabilitation, medication, and others.Conclusions:This study summarizes the best evidence for managing of dyspnea in patients with ILD, which can inform the development of appropriate interventions by healthcare professionals. Healthcare professionals need to develop dyspnea management strategies that consider the cultural context, clinical situation, and patient's willingness.
